Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-18

Clinical Trial Update: Oral FMT (Fecal Microbial Transplant) in Subjects with Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

Clinical trial update for an early-phase 1 study of oral fecal microbiota transplant in people with Multiple Sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Fecal Microbiota Transplant (FMT) (fecal microbiota transplant)

Snippet

Sponsor: Griffin Hospital | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING